Idexx Laboratories
IDXX
1,068 hedge funds and large institutions have $36.7B invested in Idexx Laboratories in 2023 Q2 according to their latest regulatory filings, with 82 funds opening new positions, 387 increasing their positions, 391 reducing their positions, and 61 closing their positions.
40% more call options, than puts
Call options by funds: $129M | Put options by funds: $91.8M
34% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 61
1% more funds holding
Funds holding: 1,055 → 1,068 (+13)
1% more capital invested
Capital invested by funds: $36.5B → $36.7B (+$285M)
0.06% more ownership
Funds ownership: 87.99% → 88.06% (+0.06%)
1% less repeat investments, than reductions
Existing positions increased: 387 | Existing positions reduced: 391
19% less funds holding in top 10
Funds holding in top 10: 31 → 25 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$103M |
| 2 |
JP Morgan Chase
New York
|
+$68.7M |
| 3 |
Man Group
London,
United Kingdom
|
+$59.1M |
| 4 |
State Street
Boston,
Massachusetts
|
+$46.6M |
| 5 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$46.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$292M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$118M |
| 3 |
Millennium Management
New York
|
-$115M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$94M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$56.9M |
IDXX Hedge Fund Activity: Q2 2023 in Review
1,068 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q2 2023, worth a combined $36.7B — up 0.78% from $36.5B a quarter earlier.
Buyers outnumbered sellers: 82 funds opened new IDXX positions and 61 closed out — a net gain of 21 holders — while 387 added to existing stakes and 391 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $103M. The largest seller was Citadel Advisors, cutting an estimated $292M.
- 1,068 institutional investors held Idexx Laboratories (IDXX) as of Q2 2023, up from 1,055 in Q1 2023.
- Funds reported $36.7B of Idexx Laboratories stock for Q2 2023, up 0.78% quarter-over-quarter.
- 82 funds opened new Idexx Laboratories positions in Q2 2023 and 61 closed out, a net change of +21 holders.
- The largest Idexx Laboratories buyer in Q2 2023 was AllianceBernstein, an estimated $103M added.
- The largest Idexx Laboratories seller in Q2 2023 was Citadel Advisors, an estimated $292M sold.
Based on aggregated 13F filings for Q2 2023.